Could Alzheimer’s testing move out of specialist centers? Roche’s pTau217 blood test just cleared a major hurdle
Roche has secured FDA clearance for Elecsys pTau217, a single-biomarker blood test capable of supporting both rule-in and rule-out assessment of Alzheimer’s-associated amyloid pathology across primary and specialty care.
